7 Biggest Mid-Day Losers For Wednesday

Galena Biopharma Inc GALE shares dropped 85 percent to $0.310 after the company reported the discontinuation of Phase 3 PRESENT clinical trial due to futility of study.
Lipocine Inc LPCN shares tumbled 51.8 percent to $3.03 following announcement of a Complete Response Letter from the FDA. The response letter noted deficiencies in dosing algorithm on label.
Esperion Therapeutics Inc ESPR shares fell 38.2 percent to $9.99 after failing to reach an agreement with the FDA regarding a definitive approval path for its ETC-1002, a cholesterol-lowering pill. JP Morgan downgraded Esperion Therapeutics from Overweight to Neutral and lowered the price target from $50.00 to $15.00, while Credit Suisse also downgraded the stock from Neutral to Underperform and lowered the price target from $23.00 to $10.00.
Eclipse Resources Corp ECR shares declined 16 percent to $3.45. Eclipse Resources reported an offering of 37.5 million shares of common stock. The company also raised its production guidance to 205-210 MMcfe per day for 2016.
Kitov Pharmaceuticals Holdings Ltd (ADR) KTOV shares dropped 10 percent to $3.05 as the company reported the pricing of its $12 million follow-on public offering in the U.S.A.
China Ceramics Co Ltd CCCL shares fell 7.4 percent to $2.64 after the company reported the settlement of class action litigation.
Southwestern Energy Company SWN shares slipped 5 percent to $13.19. Southwestern Energy reported a 75 million share offering to replay part of loan.

Market News and Data brought to you by Benzinga APIs

-

-

-

-

-

-

-

25% Off Benzinga's Most Powerful Trading Tools

-

-

-

-

-

-

-

7 Biggest Mid-Day Losers For Wednesday